ipi-145
Showing 1 - 10 of 10
Chronic Lymphocytic Leukemia Trial in Boston (IPI-145, Fludarabine, Cyclophosphamide)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- IPI-145
- +3 more
-
Boston, Massachusetts
- +1 more
Mar 10, 2022
Healthy Trial in Lenexa (IPI-145 (duvelisib), IPI-145)
Completed
- Healthy
- IPI-145 (duvelisib)
- IPI-145
-
Lenexa, Kansas(unnamed)
Mar 15, 2021
Healthy Trial in Zuidlaren (IPI-145)
Completed
- Healthy
- IPI-145
-
Zuidlaren, NetherlandsPharmaceuticals Research Association (PRA)
Mar 15, 2021
Healthy Volunteers Trial in Zuidlaren (IPI-145, Placebo)
Completed
- Healthy Volunteers
- IPI-145
- Placebo
-
Zuidlaren, NetherlandsPRA International
Mar 15, 2021
Hepatic Impairment Trial in Miami (IPI-145)
Completed
- Hepatic Impairment
- IPI-145
-
Miami, Florida(unnamed)
Mar 15, 2021
Rheumatoid Arthritis Trial in Worldwide (IPI-145, Placebo)
Completed
- Rheumatoid Arthritis
- IPI-145
- Placebo
-
Pleven, Bulgaria
- +63 more
Mar 15, 2021
Lymphoma, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in United States (IPI-145, Rituximab, Bendamustine)
Completed
- Lymphoma
- +3 more
- IPI-145
- +2 more
-
Denver, Colorado
- +3 more
Jul 7, 2016
Leukemia Trial (IPI-145, Follow-up Visit/Call)
Withdrawn
- Leukemia
- IPI-145
- Follow-up Visit/Call
- (no location specified)
Jan 3, 2014